Financial insights of RXST

MyFinsight

For the quarter ending 2025-09-30, RXST made $30,340K in revenue. -$9,639K in net income. Net profit margin of -31.77%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Sales	30,340	33,637	37,895	35,314
Cost of sales	6,113	8,447	9,566	10,094
Gross profit	24,227	25,190	28,329	25,220
Selling, general and administrative	27,345	28,976	28,636	25,608
Research and development	9,060	10,217	10,367	8,838
Total operating expenses	36,405	39,193	39,003	34,446
Loss from operations	-12,178	-14,003	-10,674	-9,226
Interest expense	4	5	6	5
Interest and other income	2,376	2,254	2,508	2,906
Loss before income taxes	-9,806	-11,754	-8,172	-6,325
Income tax expense	10	32	18	13
Net loss	-9,816	-11,786	-8,190	-6,338
Unrealized gain (loss) on short-term investments	178	-146	-157	633
Foreign currency translation (loss) gain	-1	14	6	6
Total other comprehensive loss	177	-132	-151	639
Comprehensive loss	-9,639	-11,918	-8,341	-5,699

Earnings per share, basic	-0.24	-0.29	-0.2	-0.16
Earnings per share, diluted, total	-0.24	-0.29	-0.2	-0.16
Weighted average number of shares outstanding, basic, total	40,965,219	40,743,786	40,509,646	39,788,621
Weighted average number of shares outstanding, diluted	40,965,219	40,743,786	40,509,646	39,788,621